Immunome's total assets for Q3 2024 were $256.90M, a decrease of -13.27% from the previous quarter. IMNM total liabilities were $41.99M for the fiscal quarter, a -0.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.